English
Aims and scope Subscription Info for authors Editorial Board Contacts
International journal of Immunopathology, allergology, infectology.

Rotaviral infection: epidemiology aspects, methods of prophylactic

Lyahovskaya N.V., Dmitrachenko T.I., Semenov V.M., Gudkov V.G., Virinskaya A.S., Burak I.I., Hnykov A.M.

Rotaviral infection (RVI) plays an important role in the total structure of pediatric and adult morbidity in developed and developing countries. In acute intestinal infections structure the part of RVI is 35,54% (50,48% amongst intestinal infections with the known agent). One observe the significant growth of RVI morbidity in children of early age (several months of living). Among the all patients with RVI the children of the 1st year of life compose 20,3632,14%< children between 0 and 6 months 7,27 11,2%, and children aged 02 months 1,02%. In 38,79% of hospitalized patients below 18 RVI appears been accompanied by the other infectious or somatic pathology as the background. Nosocomial propagation of RVI is alleviated by common asymptomatic carriage of rotavirus which is found in 9,82,96% of examined children aged 03 years who were hospitalized with infectious and somatic pathology not expressed by symptoms of gastrointestinal tract lesions. Anolyte solution with pH 6.87, redox potential +950 mV and concentration of active chlorine (Cach) 200 mg/dl possesses significant antiviral activity against rotavirus.

Keywords

Rotaviral infection, morbidity, nosocomial rotaviral infection, asymptomatic release of rotavirus, disinfection.

Fulltext in PDF

Open file
Size: 513 KB

Reference

Lyahovskaya N.V., Dmitrachenko T.I., Semenov V.M., Gudkov V.G., Virinskaya A.S., Burak I.I., Hnykov A.M. Immunopathology, allergology, infectology 2013; 3:73-79